Ketamine therapy has increasingly become a promising option for individuals seeking effective mental health treatment, especially for conditions like treatment-resistant depression (TRD). Ketamine is one of the only anesthesia medications that does not suppress the body’s ability to protect its airway, suppress the respiratory system or cardiovascular system. Its potential benefits for individuals with kidney issues and minimal interactions with other medications make it an ideal option for many.

For millions of people worldwide, depression is a debilitating condition that disrupts daily life and diminishes joy. While many respond positively to traditional treatments such as SSRIs (Selective Serotonin Reuptake Inhibitors) and SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), others find themselves in a frustrating position—medications and therapies that work for others simply don't bring relief. These individuals may be suffering from Treatment-Resistant Depression (TRD), a more complex form of depression.

A diverse range of psychedelic substances has been explored in clinical research programs for their potential impact on a range of mental health conditions. These conditions include severe treatment-resistant depression, terminal-illness related depression, ALS, end-of-life anxiety, severe treatment-resistant anxiety, generalized anxiety, and PTSD. Among the substances being researched are LSD, MDMA, and psilocybin.

For more information on the risks and benefits of ketamine, check out Andrew Huberman's latest podcast to learn more.

Treatment-resistant depression is a severe and debilitating condition that affects millions of people worldwide. Those with depression are roughly three times more likely than the general population to commit violent crimes. Traditional antidepressant medications and therapies may not always provide relief for these individuals, leading researchers and healthcare providers to explore alternative treatments. One such treatment that has gained attention is ketamine.

How LSD assisted psychotherapy is used to treat anxiety, OCD,  PTSD, depression and in healthcare.

How MDMA assisted psychotherapy is used to treat PTSD, depression and anxiety in healthcare.

How psilocybin assisted psychotherapy is used to treat PTSD, depression and anxiety.

With many patients hearing about the success that Ketamine (through both IV treatments or assisted psychotherapy) is having on Treatment Resistant Depression, suicidal ideations and PTSD, more of them are interested in knowing if their health insurance covers Ketamine treatments. Find out the answers to all your questions surrounding medication assistance, insurance reimbursement, and Ketamine treatments.

Brain injuries are a serious problem in the United States. Each year, an estimated 2.5 million people suffer a traumatic brain injury (TBI) and about 5.3 million people have post-traumatic stress disorder (PTSD). These mental health conditions can be life-altering, and often require long-term treatment. And until recently, there was a big unknown on how to effectively treat both PTSD and TBI.

New study shows that administering both CBD and Ketamine together can work as an anti-depressant.